vancomycin has been researched along with N-(1H-benzimidazol-2-yl)-1-ethyl-4-hydroxy-2-oxo-3-quinolinecarboxamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huddar, S; Jang, S; Kim, HJ; Lee, S; Park, CM | 1 |
1 other study(ies) available for vancomycin and N-(1H-benzimidazol-2-yl)-1-ethyl-4-hydroxy-2-oxo-3-quinolinecarboxamide
| Article | Year |
|---|---|
Discovery of 4-hydroxy-2-oxo-1,2-dihydroquinolines as potential inhibitors of Streptococcus pneumoniae, including drug-resistant strains.
Topics: Anti-Bacterial Agents; Drug Design; Drug Resistance, Bacterial; High-Throughput Screening Assays; Molecular Structure; Quinolines; Streptococcus pneumoniae | 2020 |